IHH Healthcare

SINGAPORE (Feb 23): IHH Healthcare Berhad has declared a loss of RM42.5 million ($13.5 million) as compared to RM415.8 million in earnings a year ago, led by foreign exchange losses on borrowings as well as fair value losses.

SINGAPORE (Dec 23): The healthcare sector is expected to overcome near-term headwinds and enjoy healthy growth prospects from 2017, according to DBS Group Research.

SINGAPORE (Dec 7): Why would medical tourists have coronary artery bypass grafting (CABG) surgery done in Singapore for US$54,500 ($77,350), when hospitals in Thailand and Malaysia offer the same for about or less than half the price?

SINGAPORE (Nov 25): IHH Healthcare has reported earnings of RM173.3 million ($38.1 million) for 3QFY16, a 46% jump from the earnings of RM118.5 million in FY15, due to lower foreign exchange losses on Acibadem Holdings’ non-Turkish Lira borrowings.

SINGAPORE (Oct 6): Fullerton Healthcare Corp has lodged its draft listing prospectus on Sept 28, indicating its intention to sell 140.3 million shares, excluding the overallotment option, at an “indicative” price of $1.73 a share.

SINGAPORE (Aug 25): IHH Healthcare posted earnings of RM246.1 million ($82.7 million) for 2Q16, an 8% increase from the earnings of RM228.1 million in 2Q15, thanks to one-off gains.

SINGAPORE (July 20): KGI Fraser Securities believes Singapore’s healthcare sector will continue to outperform the general market, but advises investors to wait for price pullbacks before accumulating the stocks.

SINGAPORE (July 13): UOB Kay Hian has raised its target price for IHH Healthcare from $2.09 to $2.31 as the company is set to open three more hospital projects, but maintained a “hold” recommendation given the stock’s lofty valuations.

SINGAPORE (July 5): DBS Vickers projects total healthcare expenditure in Singapore to triple by 2030, rising to $44 billion from $17 billion in 2013, given its ageing population.